Confidence in the company rose as shares for both AbbVie and its parent company, Abbott Laboratories, increased on the first day of trading in the New Year. AbbVie's stock opened yesterday at US $ ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

You can be a little greedy sometimes and find great stocks that possess solid growth prospects and also pay dividends.

However, arguably the next best thing is for a company to belong to the elite group known as Dividend Kings. To qualify, a ...

On CNBC's “Mad Money Lightning Round,” Jim Cramer said AbbVie Inc. ABBV is doing “very, very well.” However, he added that Abbott Laboratories ABT remains his favorite in the group right now.

Keith Speights (AbbVie): If you like Abbott, you might love AbbVie. The big drugmaker spun off from Abbott in 2013. Since then, it has increased its dividend by a whopping 288%. Thanks to the time ...

And since it split from Abbott in 2013, AbbVie has raised its payout by 288%. The ability to maintain a solid dividend program for years is an incredibly attractive quality to long-term investors.

Abbott Laboratories began paying dividends more than a century ago. AbbVie offers something for nearly every investor. Johnson & Johnson is an especially good pick for risk-averse investors.